{
  "docId": "019de072-8046-72ee-8797-71c9ff7422eb",
  "docSlug": "98d74c454dfdfefd8fb9993ff5213b70",
  "documentTitle": "Hillevax | IPO Presentation Deck | 24 slides",
  "authorId": "hillevax",
  "authorName": "Hillevax",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 15,
  "pageCount": 24,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "peer_benchmark",
  "function": "compare_peers",
  "density": "overcrowded",
  "nDataPoints": 40,
  "notes": "Includes two tables: Pediatric safety and Adult safety. Disclaimer notes data is not head-to-head.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-8046-72ee-8797-71c9ff7422eb/15",
  "deckHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb",
  "deckJsonHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb.json",
  "deckAnchorHref": "/decks/019de072-8046-72ee-8797-71c9ff7422eb#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.28,
        "x": 0.04,
        "y": 0.85
      },
      "kind": "disclaimer",
      "text": "These data are presented for informational purposes only, as the comparisons in the tables to the right are not based on head-to-head clinical studies and may not be comparable due to differences in vaccine design, disease under evaluation, trial designs and populations studied.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3338a03-6cd5-46d4-91bc-e297802a129a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.26,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": ">4,500 subjects (839 pediatric subjects) received vaccine in clinical studies. In adults, local AEs all mild/moderate with systemic AEs similar to placebo. Infant AEs largely mild to moderate with short duration (<3-4 days)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "558514cb-f629-4301-b1a4-b17bf35cc16c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.62,
        "x": 0.35,
        "y": 0.15
      },
      "kind": "table",
      "text": "Pediatric safety table comparing HIL-214 to Prevnar 13, Rotarix, RotaTeq, Daptacel, M-M-R II, Varivax, ProQuad, OPV",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a6c3329-ef22-4654-ada6-86ec7429f3c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.62,
        "x": 0.35,
        "y": 0.55
      },
      "kind": "table",
      "text": "Adult safety table comparing HIL-214 to Comirnaty, Moderna, Gardasil 9, Afluria, FluBlok, Shingrix",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8a70cfe-eb6e-443d-a31a-c7a3d36ac7e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.62,
        "x": 0.35,
        "y": 0.06
      },
      "kind": "title",
      "text": "HIL-214 clinical AE profile comparable to commercial vaccines",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ecf05dd-64d0-4a49-ab6c-797dbb5be4a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.12,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "SAFETY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfbfd2c8-0b8d-4679-9d91-b3d1f6c5154d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "afd705f4-47ea-4e60-ae59-bd3afc6692b2",
      "evidence": "Side-by-side table comparison of clinical safety data against industry benchmarks.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 16,
      "from": 13,
      "beatId": "203d2e43-a365-49ec-802a-f481a270533f",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 13-16 present clinical data supporting HIL-214's efficacy and safety",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}